The Food and Drug Administration has approved a highly effective HIV-prevention medication that nearly eliminated the virus' spread in clinical trials, Gilead Sciences reported.

Lenacapavir is significantly more effective than the existing oral HIV-prevention drugs, according to experts, but there's concern that its full potential might remain unrealized amid the Trump administration's federal cuts and cancellations of research grants.